DK2897594T3 - Farmaceutisk sammensætning - Google Patents
Farmaceutisk sammensætning Download PDFInfo
- Publication number
- DK2897594T3 DK2897594T3 DK13771084.4T DK13771084T DK2897594T3 DK 2897594 T3 DK2897594 T3 DK 2897594T3 DK 13771084 T DK13771084 T DK 13771084T DK 2897594 T3 DK2897594 T3 DK 2897594T3
- Authority
- DK
- Denmark
- Prior art keywords
- pharmaceutical composition
- pharmaceutical
- composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/44—Elemental carbon, e.g. charcoal, carbon black
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
- A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Addiction (AREA)
- Inorganic Chemistry (AREA)
- Psychiatry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Toxicology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP12185339 | 2012-09-21 | ||
EP13160799 | 2013-03-25 | ||
PCT/EP2013/069570 WO2014044794A2 (en) | 2012-09-21 | 2013-09-20 | Pharmaceutical composition |
Publications (1)
Publication Number | Publication Date |
---|---|
DK2897594T3 true DK2897594T3 (da) | 2020-06-29 |
Family
ID=49293599
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK13771084.4T DK2897594T3 (da) | 2012-09-21 | 2013-09-20 | Farmaceutisk sammensætning |
Country Status (8)
Country | Link |
---|---|
US (3) | US10449158B2 (da) |
EP (1) | EP2897594B1 (da) |
JP (1) | JP6456830B2 (da) |
CN (2) | CN111053759A (da) |
CA (1) | CA2885278A1 (da) |
DK (1) | DK2897594T3 (da) |
ES (1) | ES2801801T3 (da) |
WO (1) | WO2014044794A2 (da) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK2897594T3 (da) * | 2012-09-21 | 2020-06-29 | Ferring Bv | Farmaceutisk sammensætning |
EP2978413A1 (en) | 2013-03-25 | 2016-02-03 | Ferring BV | Composition for the treatment of disease |
CN105362496A (zh) * | 2015-06-13 | 2016-03-02 | 国网山东省电力公司临沂供电公司 | 一种用于治疗电力职工电光性眼炎的防护品 |
KR20180070591A (ko) * | 2015-10-26 | 2018-06-26 | 다이이찌 산쿄 가부시키가이샤 | 다공질 재료의 대장 또는 소장 하부에 대한 딜리버리 제제 |
WO2018063216A1 (en) * | 2016-09-29 | 2018-04-05 | M Pharmaceutical Usa Inc. | Dual compartment capsule for the administration of orlistat |
GB2569119A (en) * | 2017-12-05 | 2019-06-12 | Rainbow Valley Nutrients Ltd | An aqueous beverage containing microencapsulated food supplement |
MX2021001394A (es) | 2018-08-05 | 2021-04-12 | Da Volterra | Metodo para mejorar la eficacia de un agente anticanceroso. |
US20210290741A1 (en) | 2018-08-05 | 2021-09-23 | Da Volterra | Compositions for the treatment of graft versus host disease |
EP3610860A1 (en) * | 2018-08-15 | 2020-02-19 | Rheinisch-Westfälische Technische Hochschule (RWTH) Aachen | Composition of carbon dioxide absorbent or adsorbent, whereby the said composition contains a polymeric coating selected from silicone rubber and cellulose |
DE102021127957A1 (de) | 2021-10-27 | 2023-04-27 | Rheinisch-Westfälische Technische Hochschule Aachen, Körperschaft des öffentlichen Rechts | Umhüllte Wirkstoffformulierung zu kontrollierten in vivo-Aufnahme von CO2 |
EP4422595A1 (de) | 2021-10-27 | 2024-09-04 | O11-biomedical GmbH | Umhüllte wirkstoffformulierung zu kontrollierten in vivo-aufnahme von co2 |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5489010A (en) * | 1977-12-27 | 1979-07-14 | Kureha Chem Ind Co Ltd | Spherical activated charcoal antidote |
IT1230576B (it) * | 1988-10-20 | 1991-10-28 | Angeli Inst Spa | Formulazioni farmaceutiche per via orale a liberazione selettiva nel colon |
US5843479A (en) * | 1993-02-26 | 1998-12-01 | The Procter & Gamble Company | Bisacodyl dosage form with multiple enteric polymer coatings for colonic delivery |
WO1998022096A1 (en) * | 1996-11-15 | 1998-05-28 | The Procter & Gamble Company | Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery |
US6706263B2 (en) * | 1999-04-30 | 2004-03-16 | Kibow Biotech Inc. | Composition for alleviating symptoms of uremia in patients |
US20040166248A1 (en) * | 2000-12-15 | 2004-08-26 | Sheng-Hsin Hu | Coated activated carbon |
US7163696B2 (en) * | 2001-10-11 | 2007-01-16 | Pfizer Inc. | Pharmaceutical formulations |
US8048413B2 (en) * | 2006-05-17 | 2011-11-01 | Helene Huguet | Site-specific intestinal delivery of adsorbents, alone or in combination with degrading molecules |
US8110186B2 (en) * | 2006-09-18 | 2012-02-07 | Chelatexx, LLC | Method to maintain the efficacy of orlistat |
WO2008048469A2 (en) * | 2006-10-13 | 2008-04-24 | Actavis Group Pct Hf | Controlled-release coated dosage forms containing galantamine |
WO2009049239A1 (en) | 2007-10-12 | 2009-04-16 | Ocera Therapeutics, Inc. | Use of adsorbent carbon microspheres to treat pouchitis |
EP2538930B1 (en) | 2010-02-23 | 2016-06-15 | Da Volterra | Formulations for oral delivery of adsorbents in the gut |
TWI643623B (zh) | 2011-10-03 | 2018-12-11 | 菲瑞茵公司 | 用於瘻管之治療的組成物 |
DK2897594T3 (da) * | 2012-09-21 | 2020-06-29 | Ferring Bv | Farmaceutisk sammensætning |
EP2978413A1 (en) | 2013-03-25 | 2016-02-03 | Ferring BV | Composition for the treatment of disease |
-
2013
- 2013-09-20 DK DK13771084.4T patent/DK2897594T3/da active
- 2013-09-20 JP JP2015532423A patent/JP6456830B2/ja active Active
- 2013-09-20 CA CA2885278A patent/CA2885278A1/en active Pending
- 2013-09-20 US US14/429,806 patent/US10449158B2/en active Active
- 2013-09-20 WO PCT/EP2013/069570 patent/WO2014044794A2/en active Application Filing
- 2013-09-20 CN CN201911389038.1A patent/CN111053759A/zh active Pending
- 2013-09-20 ES ES13771084T patent/ES2801801T3/es active Active
- 2013-09-20 CN CN201380060120.4A patent/CN104797243A/zh active Pending
- 2013-09-20 EP EP13771084.4A patent/EP2897594B1/en active Active
-
2020
- 2020-12-10 US US17/117,599 patent/US11712422B2/en active Active
-
2023
- 2023-06-12 US US18/208,658 patent/US20240016753A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
EP2897594A2 (en) | 2015-07-29 |
US10449158B2 (en) | 2019-10-22 |
JP2015529233A (ja) | 2015-10-05 |
CN104797243A (zh) | 2015-07-22 |
US20210196647A1 (en) | 2021-07-01 |
US20150245999A1 (en) | 2015-09-03 |
CN111053759A (zh) | 2020-04-24 |
WO2014044794A3 (en) | 2014-06-19 |
JP6456830B2 (ja) | 2019-01-23 |
ES2801801T3 (es) | 2021-01-13 |
CA2885278A1 (en) | 2014-03-27 |
US11712422B2 (en) | 2023-08-01 |
US20240016753A1 (en) | 2024-01-18 |
WO2014044794A2 (en) | 2014-03-27 |
EP2897594B1 (en) | 2020-04-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK3181128T3 (da) | Farmaceutisk nilotinib-sammensætning | |
SMT201700008B (it) | Composizione farmaceutica | |
DK2694038T3 (da) | Farmaceutisk sammensætning | |
DK3030262T3 (da) | Kombineret farmaceutisk sammensætning | |
SI3725778T1 (sl) | Formulacije enzalutamida | |
BR112014003052A2 (pt) | composições farmacêuticas | |
BR112015002738A2 (pt) | composto , e , composição farmacêutica | |
FR2997014B1 (fr) | Composition sterile dermo-injectable | |
DK2939692T3 (da) | Nasal influenzavaccinesammensætning | |
BR112014032798A2 (pt) | composição | |
DK3246018T3 (da) | Farmaceutisk sammensætning | |
CO6930367A2 (es) | Composiciones farmaceúticas | |
ZA201501930B (en) | Pharmaceutical composition | |
EP2934454C0 (en) | ANTI-DANDRUFF COMPOSITION | |
EE201300005A (et) | Ravimkoostis | |
ME03413B (me) | Kompozicije које sadrže peg i askorbat | |
DK2897594T3 (da) | Farmaceutisk sammensætning | |
HUE040370T2 (hu) | Gyógyszerkészítmények | |
EP2832730A4 (en) | MIRABEGRAPHIC PHARMACEUTICAL COMPOSITION | |
DK2815752T3 (da) | Oral farmaceutisk sammensætning | |
CL2014003283A1 (es) | Formulación farmacéutica. | |
EP2920370A4 (en) | POST | |
EP2769718A4 (en) | MEDICAL COMPOSITION | |
EP2883547A4 (en) | MEDICINE | |
HK1204947A1 (zh) | 滅菌組合物 |